The following table depicts membership in Centene’s managed care organizations by member category at December 31, 2006 and 2005:
Statement of Operations
| - | For the 2006 fourth quarter, revenues increased 64.8% to $697.4 million from $423.2 million in the 2005 fourth quarter. Our fourth quarter 2006 revenue in Kansas and Missouri totaled $79.6 million. |
| - | The HBR for Centene’s Medicaid and SCHIP populations, which reflects medical costs as a percent of premium revenues, was 82.1% for the three months ended December 31, 2006, a decrease of 0.2% over the comparable 2005 period. The HBR for the three months ended December 31, 2006 did not include any overall adverse medical cost development related to prior periods. |
| - | General and administrative (G&A) expense as a percent of revenues for the Medicaid Managed Care segment was 12.7% in the fourth quarter of 2006 compared to 10.3% in the fourth quarter of 2005, increasing primarily because of premium taxes enacted in certain markets and FirstGuard exit costs. Fourth quarter 2006 premium taxes were $17.4 million. The Medicaid Managed Care G&A ratio would have been 10.4% excluding those premium taxes, and 9.3% excluding the premium taxes and $7.4 million of FirstGuard exit costs. |
| - | Operating earnings of $18.7 million, including $7.4 million of FirstGuard exit costs, compared to $20.4 million in the 2005 fourth quarter. |
| - | Earnings per diluted share of $0.31. Earnings per diluted share of $0.41, excluding the FirstGuard exit costs, compared to $0.31 in the 2005 fourth quarter. |
| - | For the year ended December 31, 2006, revenues increased 51.3% to $2.3 billion from $1.5 billion in 2005. Our 2006 revenues in Kansas and Missouri totaled $317.0 million. Medicaid Managed Care G&A expenses including premium tax and FirstGuard exit costs as a percent of revenues increased to 12.6% in 2006 compared to 10.5% in 2005. Net loss in 2006 of $43.6 million, or $1.01 per diluted share, including a non-cash intangible asset impairment charge related to the loss of the Kansas contract of $87.1 million pre-tax and the FirstGuard exit costs of $7.4 million pre-tax. Net earnings, excluding the impairment charge and exit costs, were $45.9 million or $1.03 per diluted share in 2006. |
Balance Sheet and Cash Flow
At December 31, 2006, the Company had cash and investments of $508.7 million, including $479.8 million held by its regulated entities and $28.9 million held by its unregulated entities. Medical claims liabilities totaled $280.4 million, representing 46.4 days in claims payable.
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 5
A reconciliation of the Company’s change in days in claims payable from the immediately preceding quarter-end is presented below:
| | | | | |
| Days in claims payable, September 30, 2006 | | | 45.3 | |
| Increase in claims inventory | | | 1.1 | |
| Days in claims payable, December 31, 2006 | | | 46.4 | |
| | | | | |
Outlook
The table below depicts the Company’s guidance for the 2007 first quarter and full year:
| | | | | | |
| | | Q1 2007 | | 2007 | |
| | | Low | | High | | Low | | High | |
| Revenue (in millions) | | $ | 635 | | $ | 645 | | $ | 2,700 | | $ | 2,800 | |
| Earnings per diluted share | | $ | 0.24 | | $ | 0.27 | | $ | 1.51 | | $ | 1.61 | |
| | | | | | | | | | | | | | |
J. Per Brodin, Centene’s Chief Financial Officer, stated, “The 2007 guidance reflects our previously announced intention to begin reporting our revenue net of premium taxes. This guidance also excludes any gain or loss from the sale of our Missouri health plan or tax benefits from the stock of our Kansas health plan and the effect of the tentative Texas Foster Care award. Our expected sequential change in EPS is summarized as follows:
| | Low | | High | |
Q4 2006 adjusted non-GAAP EPS | | $ | 0.41 | | $ | 0.41 | |
Q4 2006 FirstGuard net earnings | | | (0.14 | ) | | (0.14 | ) |
Reallocated corporate overhead | | | (0.05 | ) | | (0.05 | ) |
Profit improvement and growth | | | 0.02 | | | 0.05 | |
Q1 2007 earnings per diluted share | | $ | 0.24 | | $ | 0.27 | |
“The reallocated corporate overhead costs represent the centralized infrastructure for managing claims payment, IT, finance and other costs needed to support our FirstGuard operations. Our growth plans require us to maintain the existing infrastructure and will allow us to operate at an appropriate G&A ratio in 2007.”
Conference Call
As previously announced, the Company will host a conference call Tuesday, February 6, 2007, at 8:30 A.M. (Eastern Time) to review the financial results for the fourth quarter and year ended December 31, 2006, and to discuss its business outlook. Michael F. Neidorff and J. Per Brodin will host the conference call. Investors are
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 6
invited to participate in the conference call by dialing 800-273-1254 in the U.S. and Canada, 706-679-8592 from abroad, or via a live Internet broadcast on the Company's website at www.centene.com, under the Investor Relations section. A replay will be available for on-demand listening shortly after the completion of the call until 11:59 P.M. (Eastern Time) on February 20, 2007 at the aforementioned URL, or by dialing 800-642-1687 in the U.S. and Canada, or 706-645-9291 from abroad, and entering access code 6573810.
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures in this release as the Company believes that these figures are helpful in allowing individuals to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently.
The non-GAAP information presented above in the “highlights” table, fourth bullet under "Fourth Quarter Summary" and fifth and sixth bullets under "Statement of Operations" excludes the non-cash intangible asset impairment charge related to the Kansas contract non-renewal notification and exit costs for the Kansas and Missouri health plans. This exclusion has been made in the non-GAAP financial measures as management believes that these costs are an unusual event.
The Company uses the presented non-GAAP financial measures internally to focus management on period-to-period changes in the Company's core business. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 7
The following unaudited tables reconcile the Company’s Statement of Operations for the fourth quarter and full year of 2006 on a GAAP basis to a non-GAAP basis. The non-GAAP basis excludes the FirstGuard impairment and exit costs.
| | Three Months Ended December 31, 2006 |
| | GAAP | | FirstGuard Impairment and Exit Costs | | Non-GAAP |
| | | | | | |
Total revenues | | $ | 697,400 | | $ | - | | $ | 697,400 |
Expenses: | | | | | | | | | |
Medical costs | | | 556,560 | | | - | | | 556,560 |
Cost of services | | | 15,457 | | | - | | | 15,457 |
General and administrative expenses | | | 106,637 | | | (7,349 | ) | | 99,288 |
Total operating expenses | | | 678,654 | | | (7,349 | ) | | 671,305 |
Earnings from operations | | | 18,746 | | | 7,349 | | | 26,095 |
Investment and other income, net | | | 2,736 | | | 30 | | | 2,766 |
Earnings before income taxes | | | 21,482 | | | 7,379 | | | 28,861 |
Income Tax Expense | | | 7,649 | | | 2,870 | | | 10,519 |
Net earnings | | $ | 13,833 | | $ | 4,509 | | $ | 18,342 |
| | | | | | | | | |
Diluted earnings (loss) per common share | | $ | 0.31 | | | | | $ | 0.41 |
| | | | | | | | | |
| | Year Ended December 31, 2006 |
| | GAAP | | FirstGuard Impairment and Exit Costs | | Non-GAAP |
| | | | | | |
Total revenues | | $ | 2,279,020 | | $ | - | | $ | 2,279,020 |
Expenses: | | | | | | | | | |
Medical costs | | | 1,819,811 | | | - | | | 1,819,811 |
Cost of services | | | 60,735 | | | - | | | 60,735 |
General and administrative expenses | | | 346,284 | | | (13,342 | ) | | 332,942 |
Impairment loss | | | 81,098 | | | (81,098 | ) | | - |
Total operating expenses | | | 2,307,928 | | | (94,440 | ) | | 2,213,488 |
Earnings (loss) from operations | | | (28,908 | ) | | 94,440 | | | 65,532 |
Investment and other income, net | | | 7,256 | | | 30 | | | 7,286 |
Earnings (loss) before income taxes | | | (21,652 | ) | | 94,470 | | | 72,818 |
Income Tax Expense | | | 21,977 | | | 4,968 | | | 26,945 |
Net earnings | | $ | (43,629 | ) | $ | 89,502 | | $ | 45,873 |
| | | | | | | | | |
Diluted earnings (loss) per common share | | $ | (1.01 | ) | | | | $ | 1.03 |
| | | | | | | | | |
About Centene Corporation
Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including the State Children’s Health Insurance Program (SCHIP) and Supplemental Security Income (SSI). The Company operates health plans in Georgia, Indiana,
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 8
New Jersey, Ohio, Texas and Wisconsin. In addition, the Company contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, disease management, long-term care, managed vision, nurse triage, pharmacy benefits management and treatment compliance. Information regarding Centene is available via the Internet at www.centene.com.
The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company's estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.
[Tables Follow]
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 9
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
| | December 31, | |
| | 2006 | | 2005 | |
ASSETS | | | | | |
Current assets: | | | | | | | |
Cash and cash equivalents | | $ | 271,047 | | $ | 147,358 | |
Premium and related receivables, net of allowances of $155 and $343, respectively | | | 91,664 | | | 44,108 | |
Short-term investments, at fair value (amortized cost $67,199 and $56,863, respectively) | | | 66,921 | | | 56,700 | |
Other current assets | | | 22,189 | | | 24,439 | |
Total current assets | | | 451,821 | | | 272,605 | |
Long-term investments, at fair value (amortized cost $146,980 and $126,039, respectively) | | | 145,417 | | | 123,661 | |
Restricted deposits, at fair value (amortized cost $25,422 and $22,821, respectively) | | | 25,265 | | | 22,555 | |
Property, software and equipment, net | | | 110,688 | | | 67,199 | |
Goodwill | | | 135,877 | | | 157,278 | |
Other intangible assets, net | | | 16,202 | | | 17,368 | |
Other assets | | | 9,710 | | | 7,364 | |
Total assets | | $ | 894,980 | | $ | 668,030 | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | |
Current liabilities: | | | | | | | |
Medical claims liabilities | | $ | 280,441 | | $ | 170,514 | |
Accounts payable and accrued expenses | | | 72,723 | | | 29,790 | |
Unearned revenue | | | 33,816 | | | 13,648 | |
Current portion of long-term debt and notes payable | | | 971 | | | 699 | |
Total current liabilities | | | 387,951 | | | 214,651 | |
Long-term debt | | | 174,646 | | | 92,448 | |
Other liabilities | | | 5,960 | | | 8,883 | |
Total liabilities | | | 568,557 | | | 315,982 | |
Stockholders’ equity: | | | | | | | |
Common stock, $.001 par value; authorized 100,000,000 shares; issued and outstanding 43,369,918 and 42,988,230 shares, respectively | | | 44 | | | 43 | |
Additional paid-in capital | | | 209,340 | | | 191,840 | |
Accumulated other comprehensive income: | | | | | | | |
Unrealized loss on investments, net of tax | | | (1,251 | ) | | (1,754 | ) |
Retained earnings | | | 118,290 | | | 161,919 | |
Total stockholders’ equity | | | 326,423 | | | 352,048 | |
Total liabilities and stockholders’ equity | | $ | 894,980 | | $ | 668,030 | |
See notes to consolidated financial statements.
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 10
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share data)
(Unaudited)
| Three Months Ended December 31, | | Year Ended December 31, | |
| 2006 | | 2005 | | 2006 | | 2005 | |
Revenues: | | | | | | | | | | | | |
Premium | $ | 677,137 | | $ | 416,872 | | $ | 2,199,439 | | $ | 1,491,899 | |
Service | | 20,263 | | | 6,346 | | | 79,581 | | | 13,965 | |
Total revenues | | 697,400 | | | 423,218 | | | 2,279,020 | | | 1,505,864 | |
Expenses: | | | | | | | | | | | | |
Medical costs | | 556,560 | | | 345,888 | | | 1,819,811 | | | 1,226,909 | |
Cost of services | | 15,457 | | | 2,278 | | | 60,735 | | | 5,851 | |
General and administrative expenses | | 106,637 | | | 54,639 | | | 346,284 | | | 193,913 | |
Impairment loss | | — | | | — | | | 81,098 | | | — | |
Total operating expenses | | 678,654 | | | 402,805 | | | 2,307,928 | | | 1,426,673 | |
Earnings (loss) from operations | | 18,746 | | | 20,413 | | | (28,908 | ) | | 79,191 | |
Other income (expense): | | | | | | | | | | | | |
Investment and other income | | 5,836 | | | 3,194 | | | 17,892 | | | 10,655 | |
Interest expense | | (3,100 | ) | | (1,604 | ) | | (10,636 | ) | | (3,990 | ) |
Earnings (loss) before income taxes | | 21,482 | | | 22,003 | | | (21,652 | ) | | 85,856 | |
Income tax expense | | 7,649 | | | 8,137 | | | 21,977 | | | 30,224 | |
Net earnings (loss) | $ | 13,833 | | $ | 13,866 | | $ | (43,629 | ) | $ | 55,632 | |
| | | | | | | | | | | | |
Net earnings (loss) per share: | | | | | | | | | | | | |
Basic earnings (loss) per common share | $ | 0.32 | | $ | 0.32 | | $ | (1.01 | ) | $ | 1.31 | |
Diluted earnings (loss) per common share | $ | 0.31 | | $ | 0.31 | | $ | (1.01 | ) | $ | 1.24 | |
| | | | | | | | | | | | |
Weighted average number of shares outstanding: | | | | | | | | | | | | |
Basic | | 43,263,237 | | | 42,885,900 | | | 43,160,860 | | | 42,312,522 | |
Diluted | | 44,631,117 | | | 44,812,159 | | | 43,160,860 | | | 45,027,633 | |
| | | | | | | | | | | | |
See notes to consolidated financial statements.
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 11
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
| Year Ended December 31, | |
| 2006 | | 2005 | |
| | | | | | |
Cash flows from operating activities: | | | | | | |
Net earnings (loss) | $ | (43,629 | ) | $ | 55,632 | |
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities— | | | | | | |
Depreciation and amortization | | 20,600 | | | 13,069 | |
Excess tax benefits from stock compensation | | — | | | 6,469 | |
Stock compensation expense | | 14,904 | | | 4,974 | |
Impairment loss | | 88,268 | | | — | |
Deferred income taxes | | (6,692 | ) | | 1,786 | |
Changes in assets and liabilities— | | | | | | |
Premium and related receivables | | (39,765 | ) | | (10,305 | ) |
Other current assets | | 5,352 | | | (6,177 | ) |
Other assets | | 91 | | | (525 | ) |
Medical claims liabilities | | 108,003 | | | 4,534 | |
Unearned revenue | | 20,035 | | | 8,182 | |
Accounts payable and accrued expenses | | 28,136 | | | (4,215 | ) |
Other operating activities | | (271 | ) | | 624 | |
Net cash provided by operating activities | | 195,032 | | | 74,048 | |
Cash flows from investing activities: | | | | | | |
Purchase of property, software and equipment | | (50,318 | ) | | (26,909 | ) |
Purchase of investments | | (319,322 | ) | | (150,444 | ) |
Sales and maturities of investments | | 286,155 | | | 176,387 | |
Acquisitions, net of cash acquired | | (66,772 | ) | | (55,485 | ) |
Net cash used in investing activities | | (150,257 | ) | | (56,451 | ) |
Cash flows from financing activities: | | | | | | |
Proceeds from exercise of stock options | | 6,953 | | | 5,621 | |
Proceeds from borrowings | | 94,359 | | | 45,000 | |
Payment of long-term debt and notes payable | | (17,355 | ) | | (4,552 | ) |
Excess tax benefits from stock compensation | | 3,043 | | | — | |
Common stock repurchases | | (7,833 | ) | | — | |
Other financing activities | | (253 | ) | | (413 | ) |
Net cash provided by financing activities | | 78,914 | | | 45,656 | |
Net increase in cash and cash equivalents | | 123,689 | | | 63,253 | |
Cash and cash equivalents, beginning of period | | 147,358 | | | 84,105 | |
Cash and cash equivalents, end of period | $ | 271,047 | | $ | 147,358 | |
| | | | | | |
Interest paid | $ | 10,680 | | $ | 3,291 | |
Income taxes paid | $ | 16,418 | | $ | 31,287 | |
| | | | | | |
Supplemental schedule of non-cash investing and financing activities: | | | | | | |
Common stock issued for acquisitions | $ | — | | $ | 8,991 | |
Property acquired under capital leases | $ | 366 | | $ | 5,026 | |
See notes to consolidated financial statements.
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 12
CENTENE CORPORATION
SUPPLEMENTAL FINANCIAL DATA
| Q4 | | Q3 | | Q2 | | Q1 |
| 2006 | | 2006 | | 2006 | | 2006 |
MEMBERSHIP | | | | | | | |
Medicaid Managed Care: | | | | | | |
Georgia | 308,800 | | 252,600 | | 216,000 | | — |
Indiana | 183,100 | | 198,100 | | 193,000 | | 193,000 |
New Jersey | 58,900 | | 59,100 | | 59,000 | | 57,500 |
Ohio | 109,200 | | 88,300 | | 73,100 | | 59,000 |
Texas | 298,500 | | 259,900 | | 235,800 | | 237,500 |
Wisconsin | 164,800 | | 167,100 | | 174,600 | | 175,100 |
Subtotal | 1,123,300 | | 1,025,100 | | 951,500 | | 722,100 |
Kansas | 107,000 | | 112,400 | | 117,100 | | 118,200 |
Missouri | 31,900 | | 32,200 | | 32,900 | | 34,500 |
TOTAL | 1,262,200 | | 1,169,700 | | 1,101,500 | | 874,800 |
| | | | | | | |
Medicaid | 887,300 | | 818,000 | | 755,400 | | 574,300 |
SCHIP | 216,200 | | 189,100 | | 179,700 | | 132,000 |
SSI | 19,800 | | 18,000 | | 16,400 | | 15,800 |
Subtotal | 1,123,300 | | 1,025,100 | | 951,500 | | 722,100 |
Kansas and Missouri Medicaid and SCHIP members | 138,900 | | 144,600 | | 150,000 | | 152,700 |
TOTAL | 1,262,200 | | 1,169,700 | | 1,101,500 | | 874,800 |
| | | | | | | |
Specialty Services(a): |
Arizona | 94,500 | | 94,500 | | 93,600 | | 92,300 |
Kansas | 36,600 | | 37,500 | | 39,400 | | 39,200 |
TOTAL | 131,100 | | 132,000 | | 133,000 | | 131,500 |
| | | | | | | |
(a) Includes behavioral health contracts only. |
REVENUE PER MEMBER(b) | $ | 173.75 | | $ | 169.98 | | $ | 159.33 | | $ | 157.17 |
| | | | | | | |
CLAIMS(b) | | | | | | | |
Period-end inventory | 296,100 | | 233,500 | | 186,200 | | 229,800 |
Average inventory | 195,700 | | 188,600 | | 150,100 | | 175,200 |
Period-end inventory per member | 0.23 | | 0.20 | | 0.17 | | 0.26 |
(b) Revenue per member and claims information are presented for the Medicaid Managed Care segment. |
| | | | | | | |
DAYS IN CLAIMS PAYABLE (c) | 46.4 | | 45.3 | | 42.6 | | 43.0 |
(c) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period. |
| | | | | | | |
CASH AND INVESTMENTS (in millions) | | | | | | | |
Regulated | $ | 479.8 | | $ | 411.1 | | $ | 323.9 | | $ | 314.0 |
Unregulated | | 28.9 | | | 29.0 | | | 25.5 | | | 25.8 |
TOTAL | $ | 508.7 | | $ | 440.1 | | $ | 349.4 | | $ | 339.8 |
| | | | | | | |
ANNUALIZED RETURN ON EQUITY (d) | 17.5% | | (83.8)% | | 5.4% | | 9.8% |
(d) Annualized Return on Equity is calculated as follows: (net income for quarter x 4) divided by ((beginning of period equity + end of period equity) divided by 2). |
Centene Corporation Reports Fourth Quarter 2006 Results February 6, 2007 / Page 13
HEALTH BENEFITS RATIO BY CATEGORY:
| | Three Months Ended December 31, | | Year Ended December 31, | |
| | 2006 | | 2005 | | 2006 | | 2005 | |
Medicaid and SCHIP | | | 82.1 | % | | 82.3 | % | | 82.6 | % | | 81.8 | % |
SSI | | | 91.4 | | | 105.4 | | | 87.6 | | | 97.5 | |
Specialty Services | | | 80.2 | | | 81.3 | | | 82.5 | | | 85.0 | |
GENERAL AND ADMINISTRATIVE EXPENSE RATIO BY BUSINESS SEGMENT:
| | Three Months Ended December 31, | | Year Ended December 31, | |
| | 2006 | | 2005 | | 2006 | | 2005 | |
Medicaid Managed Care | | | 12.7 | % | | 10.3 | % | | 12.6 | % | | 10.5 | % |
Specialty Services | | | 14.4 | | | 30.3 | | | 16.9 | | | 35.4 | |
MEDICAL CLAIMS LIABILITIES
(In thousands)
Four rolling quarters of the changes in medical claims liabilities are summarized as follows:
Balance, December 31, 2005 | | $ | 170,514 | |
Acquisitions | | | 1,788 | |
Incurred related to: | | | | |
Current period | | | 1,832,096 | |
Prior period | | | (12,285 | ) |
Total incurred | | | 1,819,811 | |
Paid related to: | | | | |
Current period | | | 1,555,074 | |
Prior period | | | 156,598 | |
Total paid | | | 1,711,672 | |
Balance, December 31, 2006 | | $ | 280,441 | |
Centene’s claims reserving process utilizes a consistent actuarial methodology to estimate Centene’s ultimate liability. Any reduction in the “Incurred related to: Prior period” claims may be offset as Centene actuarially determines “Incurred related to: Current period.” As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.